Gaudium IVF

Which are the latest news on Gaudium IVF?

Why is Gaudium IVF and Women Health Ltd falling/rising?

As of 05-Sep, Gaudium IVF and Women Health Ltd's stock price is declining, currently at 116.25, with a notable drop of 12.00% over the past month. Recent financial results, including a 25.7% decrease in net sales and an 83.3% decline in profit before tax, alongside reduced institutional investor participation, have contributed to negative market sentiment.

As of 05-Sep, Gaudium IVF and Women Health Ltd's stock price is falling, currently at 116.25, reflecting a decrease of 1.3 or 1.11%. The stock has been on a downward trend, having lost 8.9% over the last three days and showing a significant decline of 12.00% over the past month, which is considerably worse than the Sensex's decline of 2.44% in the same period.<BR><BR>The company's recent financial results have contributed to this negative sentiment. In June 2026, the company reported a substantial drop in net sales, which fell by 25.7% compared to the previous four-quarter average. Additionally, the profit before tax less other income saw a dramatic decline of 83.3%. Although the company is net-debt free and has a healthy long-term growth outlook, these recent negative results have overshadowed its financial stability.<BR><BR>Moreover, there has been a decrease in participation from institutional investors, who have reduced their stake by 4.08% over the previous quarter. This decline in institutional interest may indicate a lack of confidence in the company's future performance, as these investors typically have more resources to analyze the fundamentals of companies.<BR><BR>Despite outperforming its sector by 0.54% today and experiencing an increase in delivery volume, the overall trend and recent financial performance suggest that the stock is facing significant challenges, leading to its current decline.

What does Gaudium IVF do?

Gaudium IVF and Women Health Ltd is a micro-cap healthcare services company specializing in IVF treatments, with recent net sales of 19 Cr and a net profit of 2 Cr as of June 2026. Key financial metrics include a P/E ratio of 40.00 and a market cap of INR 916 Cr.

Overview: <BR>Gaudium IVF and Women Health Ltd operates in the healthcare services industry and is categorized as a micro-cap company.<BR><BR>History: <BR>The incorporation year and any status changes are not provided. The latest quarterly results reported are for June 2026, showing net sales and profit.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 19 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 2 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 916 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 40.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.10 <BR>Return on Equity: 16.08% <BR>Price-to-Book: 5.76 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the Gaudium IVF?

Gaudium IVF's peers include 3B Blackbio, Laxmi Dental, One Global Serv, Health X Platform, Hemant Surgical, Prevest Denpro, Nureca, and QMS Medical. Notable performance includes One Global Serv with a 1-year return of 111.18% and Laxmi Dental with -42.71%, while management and capital structures vary among peers.

Peers: The peers of Gaudium IVF are 3B Blackbio, Laxmi Dental, One Global Serv, Health X Platfor, Hemant Surgical, Prevest Denpro, Nureca, and QMS Medical.<BR><BR>Quality Snapshot: Excellent management risk is observed at One Global Serv, Prevest Denpro, and Laxmi Dental, while Average management risk is found at 3B Blackbio, Hemant Surgical, and QMS Medical, and the rest. Good growth is noted at Laxmi Dental, One Global Serv, and Hemant Surgical, while Below Average growth is seen at 3B Blackbio, Health X Platfor, Nureca, and the rest. Excellent capital structure is present in 3B Blackbio, Laxmi Dental, One Global Serv, and Prevest Denpro, while Good capital structure is found at Hemant Surgical and Nureca, and Average capital structure is noted at QMS Medical.<BR><BR>Return Snapshot: One Global Serv has the highest 1-year return at 111.18%, while Laxmi Dental has the lowest at -42.71%, with Gaudium IVF's 1-year return being not applicable. Additionally, Laxmi Dental, Prevest Denpro, and QMS Medical have negative six-month returns.

How big is Gaudium IVF?

As of 31st August, Gaudium IVF and Women Health Ltd has a market capitalization of 916.00 Cr, with recent net sales of 105.97 Cr and a net profit of 23.15 Cr. Shareholder's funds are 46.30 Cr, and total assets are valued at 88.51 Cr as of March 2025.

As of 31st August, Gaudium IVF and Women Health Ltd has a market capitalization of 916.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Gaudium IVF reported Net Sales of 105.97 Cr and a Net Profit of 23.15 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 46.30 Cr and Total Assets valued at 88.51 Cr.

Should I buy, sell or hold Gaudium IVF and Women Health Ltd?